Evaluating the utility of drug testing in an outpatient addiction program

Addictive Disorders and their Treatment

Volumn 8, Issue 1, 2009, Pages 22-32

  Vakili, Shervin ^a   Currie, Shawn ^a   El Guebaly, Nady ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Addiction treatment; Urine drug screens

Indexed keywords

ALCOHOL;

ADDICTION; ADOLESCENT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG SCREENING; DRUG USE; FEMALE; GOAL ATTAINMENT; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; SELF REPORT; URINALYSIS;

EID: 68049143270     PISSN: 15315754     EISSN: None     Source Type: Journal    
DOI: 10.1097/ADT.0b013e318166efc4     Document Type: Article

References (19)

1. Compton PA, Ling W, Wesson DR, et al. Urine toxicology as an outcome measure in drug abuse clinical trials: must every sample be analyzed? J Addict Dis. 1996;15:85-92.
2. Kilpatrick B, Howlett M, Sedgwick P, et al. Drug use, self report and urinalysis. Drug Alcohol Depend. 2000;58:111-116.
3. Delucchi KL, Batki SL, Moon J, et al. Urine toxicology samples in cocaine treatment trials: how many need to be tested? J Addict Dis. 2002;21:17-26.
4. Borack JI. An estimate of the impact of drug testing on the deterrence of drug use. Mil Psychol. 1998;10:17-25. (Pubitemid 128549645)
5. Kampman KM, Alterman AI, Volpicelli JR, et al. Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict Behav. 2001;15:52-59.
6. Smith ML, Shimomura ET, Summers J, et al. Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration. J Anal Toxicol. 2000;24:522-529. (Pubitemid 30757903)
7. Winhusen TM, Somoza EC, Singal B, et al. Measuring outcome in cocaine clinical trials: a comparison of sweat patches with urine toxicology and participant self-report. Addiction. 2003;98:317-324. (Pubitemid 36269570)
8. Zanis DA, McLellan AT, Randall M. Can you trust patient self-reports of drug use during treatment? Drug Alcohol Depend. 1994;35:127-132.
9. Allen JP, Litten RZ. The role of laboratory tests in alcoholism treatment. J Subst Abuse Treat. 2001;20:81-85. (Pubitemid 32178184)
10. Allen JP. Use of biomarkers of heavy drinking in health care practice. Mil Med. 2003;168:364-367.
11. Coombs RH, Ryan FJ. Drug testing effectiveness in identifying and preventing drug use. Am J Drug Alcohol Abuse. 1990;16:173-185.
12. Neale J, Robertson M. Comparisons of self-report data and oral fluid testing in detecting drug use amongst new treatment clients. Drug Alcohol Depend. 2003;71:57-64. (Pubitemid 36734859)
13. Procheska JO, DiClemente CC. Transtheoretical therapy. In: Kaslow F, ed. Comprehensive Handbook of Psychotherapy: Integrative/eclectic. Hoboken, NJ: John Wiley & Sons Inc; 2002:165-183.
14. Akinci IH, Tarter RE, Kirisci L. Concordance between verbal report and urine screen of recent marijuana use in adolescents. Addict Behav. 2001;26:613-619. (Pubitemid 32611579)
15. McLellan AT, Luborsky L, Woody GE, et al. An improved diagnostic evaluation instrument for substance abuse patients; the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26-33. (Pubitemid 10187569)
16. Friedman AS, Utada A. A method for diagnosing and planning the treatment of adolescent drug abusers (the Adolescent Drug Abuse Diagnosis [ADAD] instrument). J Drug Educ. 1989;19:285-312. (Pubitemid 20099103)
17. Wolff K, Farrell M, Marsden J, et al. A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction. 1999;94:1279-1298. (Pubitemid 29433788)
18. Bharucha-Reid R, McCann D, Schork M, et al. A comparison of self-reported drug use with a urine drug screen in a working population. Exp Clin Psychol. 1995;3:280-286.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174